 Matthew Frank
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 26 | 2024 | 262 | 5.160 |
Why?
| | Glucocorticoids | 15 | 2025 | 542 | 3.070 |
Why?
| | Hippocampus | 30 | 2025 | 950 | 3.030 |
Why?
| | Stress, Psychological | 15 | 2025 | 1138 | 2.650 |
Why?
| | HMGB1 Protein | 8 | 2019 | 51 | 2.420 |
Why?
| | Lipopolysaccharides | 19 | 2024 | 861 | 2.410 |
Why?
| | Inflammasomes | 7 | 2023 | 146 | 2.200 |
Why?
| | Inflammation | 24 | 2024 | 2882 | 1.840 |
Why?
| | Rats, Sprague-Dawley | 36 | 2025 | 2531 | 1.760 |
Why?
| | Rats | 48 | 2025 | 5610 | 1.720 |
Why?
| | Inflammation Mediators | 7 | 2018 | 510 | 1.720 |
Why?
| | Brain | 10 | 2024 | 2899 | 1.320 |
Why?
| | Encephalitis | 6 | 2018 | 137 | 1.310 |
Why?
| | Stress, Physiological | 4 | 2017 | 453 | 1.230 |
Why?
| | Mycobacterium | 5 | 2024 | 112 | 1.150 |
Why?
| | Receptors, Immunologic | 3 | 2019 | 207 | 1.090 |
Why?
| | Alarmins | 4 | 2018 | 27 | 1.080 |
Why?
| | Spike Glycoprotein, Coronavirus | 2 | 2024 | 125 | 0.950 |
Why?
| | Psychoneuroimmunology | 1 | 2025 | 10 | 0.910 |
Why?
| | Anti-Inflammatory Agents | 3 | 2023 | 482 | 0.900 |
Why?
| | Interleukin-1beta | 12 | 2025 | 392 | 0.880 |
Why?
| | Prefrontal Cortex | 3 | 2025 | 321 | 0.840 |
Why?
| | Animals | 59 | 2025 | 38080 | 0.820 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 9 | 2023 | 165 | 0.810 |
Why?
| | Probiotics | 2 | 2025 | 60 | 0.760 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 4 | 2012 | 255 | 0.720 |
Why?
| | Aging | 10 | 2018 | 1955 | 0.710 |
Why?
| | Corticosterone | 8 | 2025 | 240 | 0.650 |
Why?
| | Adaptation, Psychological | 1 | 2025 | 687 | 0.630 |
Why?
| | Mycobacteriaceae | 5 | 2023 | 32 | 0.610 |
Why?
| | Cytokines | 12 | 2018 | 2099 | 0.600 |
Why?
| | Limbic System | 1 | 2019 | 55 | 0.580 |
Why?
| | Cisterna Magna | 4 | 2013 | 8 | 0.580 |
Why?
| | Escherichia coli Infections | 4 | 2014 | 119 | 0.540 |
Why?
| | Neuroimmunomodulation | 6 | 2019 | 65 | 0.520 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2020 | 475 | 0.510 |
Why?
| | Memory Disorders | 5 | 2016 | 185 | 0.510 |
Why?
| | Male | 51 | 2025 | 71701 | 0.480 |
Why?
| | Antigens, CD | 2 | 2017 | 550 | 0.480 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 209 | 0.460 |
Why?
| | Central Nervous System | 2 | 2018 | 269 | 0.450 |
Why?
| | Down-Regulation | 1 | 2017 | 644 | 0.450 |
Why?
| | Carrier Proteins | 3 | 2015 | 752 | 0.440 |
Why?
| | Methamphetamine | 1 | 2015 | 70 | 0.430 |
Why?
| | Receptors, Glucocorticoid | 4 | 2025 | 137 | 0.410 |
Why?
| | Peripheral Nervous System Diseases | 3 | 2010 | 133 | 0.400 |
Why?
| | Memory | 4 | 2018 | 268 | 0.380 |
Why?
| | Receptors, Interleukin-1 | 2 | 2012 | 215 | 0.380 |
Why?
| | Rats, Inbred F344 | 9 | 2018 | 265 | 0.360 |
Why?
| | Neuroglia | 3 | 2011 | 173 | 0.330 |
Why?
| | Signal Transduction | 3 | 2025 | 5220 | 0.310 |
Why?
| | Mifepristone | 4 | 2019 | 63 | 0.300 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 154 | 0.290 |
Why?
| | Disease Susceptibility | 1 | 2011 | 354 | 0.290 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2025 | 198 | 0.290 |
Why?
| | Endotoxins | 1 | 2009 | 213 | 0.280 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 994 | 0.280 |
Why?
| | RNA, Messenger | 6 | 2020 | 2854 | 0.270 |
Why?
| | RNA, Antisense | 1 | 2007 | 18 | 0.260 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2007 | 88 | 0.250 |
Why?
| | Spinal Cord | 7 | 2023 | 379 | 0.250 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 76 | 0.240 |
Why?
| | Oxidative Stress | 1 | 2013 | 1376 | 0.240 |
Why?
| | Centrifugation | 1 | 2005 | 27 | 0.230 |
Why?
| | Nerve Tissue Proteins | 1 | 2009 | 607 | 0.230 |
Why?
| | Histocompatibility Antigens | 1 | 2006 | 108 | 0.230 |
Why?
| | Neuralgia | 2 | 2023 | 142 | 0.230 |
Why?
| | Helplessness, Learned | 1 | 2025 | 68 | 0.220 |
Why?
| | Interleukins | 1 | 2006 | 252 | 0.210 |
Why?
| | Cell Separation | 1 | 2005 | 311 | 0.210 |
Why?
| | Diet, Western | 1 | 2024 | 82 | 0.210 |
Why?
| | History, 21st Century | 1 | 2025 | 220 | 0.210 |
Why?
| | Pituitary-Adrenal System | 1 | 2025 | 165 | 0.210 |
Why?
| | History, 20th Century | 1 | 2025 | 328 | 0.200 |
Why?
| | Immunity, Innate | 4 | 2015 | 861 | 0.200 |
Why?
| | Dependovirus | 1 | 2024 | 77 | 0.200 |
Why?
| | Mentors | 1 | 2025 | 215 | 0.190 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 376 | 0.190 |
Why?
| | Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 7 | 0.180 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 199 | 0.180 |
Why?
| | Interleukin-6 | 5 | 2023 | 781 | 0.180 |
Why?
| | Substance-Related Disorders | 1 | 2011 | 1116 | 0.180 |
Why?
| | Extinction, Psychological | 1 | 2022 | 91 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 1 | 2024 | 505 | 0.170 |
Why?
| | Weight Gain | 1 | 2024 | 550 | 0.170 |
Why?
| | Immunization | 3 | 2018 | 404 | 0.170 |
Why?
| | Phosphate-Binding Proteins | 1 | 2020 | 6 | 0.170 |
Why?
| | Toll-Like Receptor 2 | 2 | 2013 | 120 | 0.160 |
Why?
| | Hot Temperature | 2 | 2022 | 408 | 0.160 |
Why?
| | Proteome | 1 | 2025 | 495 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 856 | 0.160 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.160 |
Why?
| | Interleukin-10 | 4 | 2014 | 311 | 0.160 |
Why?
| | Caspase 1 | 1 | 2020 | 147 | 0.160 |
Why?
| | Vaccination | 2 | 2020 | 1483 | 0.150 |
Why?
| | Depressive Disorder | 1 | 2002 | 377 | 0.150 |
Why?
| | Hyperalgesia | 3 | 2011 | 130 | 0.150 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 276 | 0.150 |
Why?
| | HEK293 Cells | 1 | 2021 | 747 | 0.150 |
Why?
| | Chronic Pain | 1 | 2023 | 283 | 0.150 |
Why?
| | Interleukin-4 | 1 | 2020 | 216 | 0.150 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 475 | 0.150 |
Why?
| | Rats, Inbred BN | 4 | 2012 | 54 | 0.140 |
Why?
| | Receptors, Pattern Recognition | 1 | 2018 | 13 | 0.140 |
Why?
| | Bacterial Vaccines | 1 | 2018 | 63 | 0.140 |
Why?
| | Humans | 15 | 2025 | 143876 | 0.140 |
Why?
| | Macrophages | 4 | 2023 | 1512 | 0.130 |
Why?
| | Blood Proteins | 1 | 2020 | 247 | 0.130 |
Why?
| | Fear | 4 | 2022 | 347 | 0.130 |
Why?
| | Genetic Therapy | 3 | 2010 | 320 | 0.130 |
Why?
| | Up-Regulation | 2 | 2013 | 863 | 0.130 |
Why?
| | Circadian Rhythm | 3 | 2018 | 514 | 0.130 |
Why?
| | Proteomics | 2 | 2025 | 1163 | 0.130 |
Why?
| | Plasmids | 2 | 2010 | 371 | 0.130 |
Why?
| | Cognition | 2 | 2018 | 1271 | 0.130 |
Why?
| | Frontal Lobe | 1 | 2018 | 161 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 192 | 0.120 |
Why?
| | Time Factors | 6 | 2016 | 7042 | 0.120 |
Why?
| | Lipid Metabolism | 1 | 2020 | 524 | 0.120 |
Why?
| | Neurogenic Inflammation | 1 | 2016 | 2 | 0.120 |
Why?
| | Affect | 1 | 2018 | 316 | 0.120 |
Why?
| | Adrenalectomy | 2 | 2014 | 70 | 0.120 |
Why?
| | Drug Synergism | 2 | 2013 | 370 | 0.120 |
Why?
| | Illness Behavior | 1 | 2014 | 8 | 0.110 |
Why?
| | Brain Mapping | 1 | 2018 | 536 | 0.110 |
Why?
| | Diet, High-Fat | 1 | 2016 | 261 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2013 | 346 | 0.110 |
Why?
| | Ventral Tegmental Area | 1 | 2015 | 60 | 0.110 |
Why?
| | Spleen | 2 | 2014 | 517 | 0.110 |
Why?
| | Anxiety | 2 | 2020 | 1093 | 0.110 |
Why?
| | Behavior, Animal | 3 | 2012 | 516 | 0.110 |
Why?
| | Circadian Clocks | 1 | 2014 | 58 | 0.110 |
Why?
| | Laparotomy | 2 | 2011 | 116 | 0.100 |
Why?
| | Nucleus Accumbens | 1 | 2015 | 152 | 0.100 |
Why?
| | Corpus Striatum | 1 | 2015 | 180 | 0.100 |
Why?
| | CD11b Antigen | 2 | 2010 | 62 | 0.100 |
Why?
| | Liver | 2 | 2014 | 1869 | 0.100 |
Why?
| | Injections, Spinal | 6 | 2010 | 109 | 0.100 |
Why?
| | Physical Conditioning, Animal | 2 | 2014 | 247 | 0.100 |
Why?
| | Injections | 2 | 2013 | 195 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 441 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2018 | 790 | 0.090 |
Why?
| | Pain | 4 | 2011 | 782 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1092 | 0.090 |
Why?
| | Interleukin-1 | 2 | 2007 | 970 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2011 | 36 | 0.090 |
Why?
| | DNA | 2 | 2010 | 1457 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2011 | 50 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 2057 | 0.080 |
Why?
| | Raphe Nuclei | 1 | 2011 | 109 | 0.080 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2010 | 61 | 0.080 |
Why?
| | Immune System | 1 | 2012 | 183 | 0.080 |
Why?
| | Fever | 1 | 2011 | 311 | 0.080 |
Why?
| | Transcription Factors | 1 | 2018 | 1754 | 0.080 |
Why?
| | Genes, fos | 1 | 2009 | 37 | 0.080 |
Why?
| | Microfilament Proteins | 1 | 2010 | 135 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2010 | 2621 | 0.070 |
Why?
| | Hyperesthesia | 2 | 2006 | 6 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2010 | 218 | 0.070 |
Why?
| | Gene Transfer Techniques | 1 | 2010 | 181 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2010 | 367 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2012 | 531 | 0.070 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2009 | 146 | 0.070 |
Why?
| | Hydrocortisone | 1 | 2009 | 311 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2014 | 1228 | 0.060 |
Why?
| | Pain Threshold | 1 | 2007 | 75 | 0.060 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 307 | 0.060 |
Why?
| | Foreign-Body Reaction | 1 | 2007 | 35 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2018 | 4183 | 0.060 |
Why?
| | Catheterization | 1 | 2007 | 185 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 2010 | 1737 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2006 | 277 | 0.060 |
Why?
| | Minocycline | 1 | 2005 | 27 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 518 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4544 | 0.060 |
Why?
| | Chemokines, CX3C | 1 | 2004 | 10 | 0.050 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 12 | 0.050 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 98 | 0.050 |
Why?
| | Constriction | 1 | 2023 | 47 | 0.050 |
Why?
| | Transduction, Genetic | 1 | 2024 | 135 | 0.050 |
Why?
| | Transgenes | 1 | 2024 | 188 | 0.050 |
Why?
| | Morphine | 1 | 2004 | 166 | 0.050 |
Why?
| | Leptin | 1 | 2024 | 239 | 0.050 |
Why?
| | Animals, Genetically Modified | 1 | 2024 | 246 | 0.050 |
Why?
| | Genetic Vectors | 1 | 2024 | 342 | 0.050 |
Why?
| | Administration, Oral | 1 | 2025 | 842 | 0.050 |
Why?
| | Electroshock | 2 | 2013 | 142 | 0.050 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 240 | 0.050 |
Why?
| | Tissue Distribution | 2 | 2016 | 330 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2006 | 896 | 0.040 |
Why?
| | Age of Onset | 1 | 2002 | 549 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2002 | 555 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2012 | 2912 | 0.040 |
Why?
| | Adiposity | 1 | 2024 | 532 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1794 | 0.040 |
Why?
| | Escherichia coli | 2 | 2016 | 834 | 0.040 |
Why?
| | Optical Fibers | 1 | 2018 | 17 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2002 | 1192 | 0.040 |
Why?
| | Pain Measurement | 2 | 2011 | 561 | 0.030 |
Why?
| | Vaccines, Inactivated | 1 | 2018 | 71 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2004 | 1177 | 0.030 |
Why?
| | Immunoassay | 1 | 2018 | 110 | 0.030 |
Why?
| | Neurons | 1 | 2006 | 1636 | 0.030 |
Why?
| | Host-Pathogen Interactions | 2 | 2011 | 369 | 0.030 |
Why?
| | Memory, Long-Term | 1 | 2016 | 12 | 0.030 |
Why?
| | Mice | 2 | 2024 | 18423 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 736 | 0.030 |
Why?
| | Hormone Antagonists | 1 | 2016 | 34 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2023 | 1524 | 0.030 |
Why?
| | Antibodies | 1 | 2018 | 402 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2004 | 1131 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 370 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 705 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2016 | 454 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 9 | 0.030 |
Why?
| | Phenotype | 1 | 2002 | 3210 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 323 | 0.030 |
Why?
| | Proteins | 1 | 2020 | 1023 | 0.030 |
Why?
| | Conditioning, Classical | 1 | 2014 | 105 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 6055 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2020 | 608 | 0.020 |
Why?
| | Injections, Intraventricular | 1 | 2012 | 55 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2899 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 131 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2011 | 89 | 0.020 |
Why?
| | Obesity | 1 | 2024 | 3046 | 0.020 |
Why?
| | Physical Stimulation | 1 | 2011 | 68 | 0.020 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2010 | 112 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2010 | 44 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2018 | 3615 | 0.020 |
Why?
| | Serotonin | 1 | 2011 | 290 | 0.020 |
Why?
| | Female | 3 | 2023 | 77455 | 0.020 |
Why?
| | Amnesia, Anterograde | 1 | 2008 | 4 | 0.020 |
Why?
| | Particle Size | 1 | 2010 | 406 | 0.020 |
Why?
| | Lactic Acid | 1 | 2010 | 308 | 0.020 |
Why?
| | Exercise Test | 1 | 2011 | 624 | 0.020 |
Why?
| | Parietal Lobe | 1 | 2008 | 59 | 0.020 |
Why?
| | Action Potentials | 1 | 2011 | 513 | 0.020 |
Why?
| | Hypothalamus | 1 | 2008 | 154 | 0.020 |
Why?
| | Cyclooxygenase 1 | 1 | 2007 | 26 | 0.020 |
Why?
| | Microinjections | 1 | 2006 | 86 | 0.020 |
Why?
| | Ligation | 1 | 2006 | 93 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 724 | 0.020 |
Why?
| | Sciatic Nerve | 1 | 2006 | 63 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2007 | 175 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2010 | 899 | 0.010 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2004 | 19 | 0.010 |
Why?
| | Receptors, HIV | 1 | 2004 | 25 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2004 | 25 | 0.010 |
Why?
| | Receptors, Cytokine | 1 | 2004 | 36 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2007 | 500 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 774 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2004 | 160 | 0.010 |
Why?
| | Drug Tolerance | 1 | 2004 | 105 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2007 | 1315 | 0.010 |
Why?
| | Neuroprotective Agents | 1 | 2005 | 142 | 0.010 |
Why?
| | Nanoparticles | 1 | 2010 | 505 | 0.010 |
Why?
| | Pain Management | 1 | 2004 | 405 | 0.010 |
Why?
| | Middle Aged | 1 | 2002 | 35428 | 0.010 |
Why?
| | Adult | 1 | 2002 | 40115 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|